| 000 | 01170 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515185136.0 | ||
| 264 | 0 | _c20091014 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1546-1718 | ||
| 024 | 7 |
_a10.1038/ng.453 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Brien, Thomas R | |
| 245 | 0 | 0 |
_aInterferon-alfa, interferon-lambda and hepatitis C. _h[electronic resource] |
| 260 |
_bNature genetics _cOct 2009 |
||
| 300 |
_a1048-50 p. _bdigital |
||
| 500 | _aPublication Type: News; Comment | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aGenome-Wide Association Study |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aInterferons |
| 650 | 0 | 4 |
_aInterleukins _xgenetics |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tNature genetics _gvol. 41 _gno. 10 _gp. 1048-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ng.453 _zAvailable from publisher's website |
| 999 |
_c19147838 _d19147838 |
||